Anika to Issue Fourth Quarter and Year-End 2020 Financial Results on Thursday, March 4, 2021
February 09 2021 - 3:00PM
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint
preservation company that creates and delivers meaningful
advancements in early intervention orthopedic care, today announced
that the Company plans to issue its fourth quarter and year-end
2020 financial results after the close of the market on Thursday,
March 4, 2021 and hold its investor conference call and
webcast on the same day, at 5:00 p.m. ET to discuss its financial
results and business highlights.
The conference call can be accessed by dialing 1-855-327-6837
(toll-free domestic) or 1-631-891-4304 (international) and
providing the conference ID number 10012940. A live audio webcast
will be available in the "Investor Relations" section of Anika's
website, www.anika.com. An accompanying slide presentation also can
be accessed via the Anika investor relations website. The call will
be archived and accessible on the same website shortly after its
conclusion.
About Anika Therapeutics, Inc.
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint
preservation company that creates and delivers meaningful
advancements in early intervention orthopedic care. We partner with
physicians to understand what they need most to treat their
patients and we develop minimally invasive products that restore
active living for people around the world. We are committed to
leading in high opportunity spaces within orthopedics, including
osteoarthritis pain management, regenerative solutions, soft tissue
repair and bone preserving joint technologies. For more
information, please visit www.anika.com.
For Investor Inquiries:Anika Therapeutics, Inc.Mark Namaroff,
781-457-9287Executive Director, Investor Relations and Corporate
Communicationsinvestorrelations@anika.com
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anika Therapeutics (NASDAQ:ANIK)
Historical Stock Chart
From Apr 2023 to Apr 2024